 |
 |
 |
 |
  |
Walter H.A. Kahr
Assistant Professor
M.D., Toronto, 1994
Ph.D., Toronto,
1994
|

Hospital for Sick Children, McMaster Building, Room 4025
416-813-7977
walter.kahr@sickkids.ca |
|

Inherited Platelet Function Disorders
Go to Lab
Homepage



Research Synopsis

|
|


|
Inherited platelet function disorders
Platelets are small, numerous blood cells that initiate and co-ordinate blood clotting at wound sites, where they adhere, secrete an assortment of molecules and support progression of the “coagulation cascade.” Platelets are also involved in the formation of arterial plaques and pathological clots, such as the arterial thrombi that cause heart attacks and strokes (both major causes of mortality in the modern world). Research in my laboratory is focused on advancing our understanding of platelet biology by studying inherited platelet disorders. For example a recent investigation into a severe disorder (ARC Syndrome) led us to identify a protein, VPS33B, involved in the formation of platelet alpha granules in their cellular precursors, megakaryocytes. Understanding the mechanisms of VPS33B-mediated platelet alpha granule formation is a current focus in my laboratory.
VPS33B is a 617 amino acid 70.6 kDa protein expressed in numerous tissues that is associated with late endosomes/lysosomes in cells. As a member of the Sec1/Munc18 protein family, VPS33B is predicted to interact with SNAREs to facilitate docking and fusion of intracellular vesicles. Efforts are underway to identify potential VPS33B binding proteins. Candidate proteins are currently being evaluated using a combination of molecular, cellular and biochemical approaches. RNAi techniques are being utilized to evaluate the loss of VPS33B function in human megakaryocytes. Candidate VPS33B binding proteins are also being knocked down using RNAi to assess their role during alpha granule biogenesis.
There are a number of collaborative studies ongoing in my laboratory. One area of research is investigating the role of the complement system and platelets in the pathogenesis of atypical hemolytic uremic syndrome (HUS). Another is investigating the recently discovered biosynthetic ability of platelets in health and disease. We are also investigating the role of myosin IIA function in platelets and megakaryocytes by examining a cohort of children with MYH9-related macrothrombocytopenia.
 |
|
|
|
|

Future Research
• Determining the role of VPS33B-interacting proteins in platelet alpha granule biogenesis
• Analysis of VPS33B structure and function
• Characterizing vesicular trafficking leading to dense granules and alpha granules in human megakaryocytes and platelets
• Identification of new proteins involved in normal platelet function from patients with inherited platelet abnormalities
|
|
|


Selected Publications
 |
Yang H, Lang S, Zhai Z, Li L , Kahr WHA , Chen P, Brkic J, Spring CM, Flick MJ, Degen JL, Freedman J, Ni H . Fibrinogen is required for maintenance of platelet intracellular and cell surface P-selectin expression. Blood 2009 Mar 30. [Epub ahead of print]
Maurer-Spurej E, Kahr WH , Carter CJ, Pittendreigh C, Cameron M, Cyr TD. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets 2008;19:342-51.
Diamandis M, Adam F, Rivard GE, Kahr WHA , Chorneyko KA, Arsenault L, Hayward CPM. Insights into abnormal hemostasis in the Quebec platelet disorder from anayses of clot lysis. J Thromb Haemost 2006;4:1086-1094.
Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C, Abdelhaleem M, Hayes JA, Williams MD, Chitayat D, Kahr WHA . Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in magakaryocyte and platelet alpha-granule biogenesis. Blood 2005;106:4159-4166.
Sheth PM, Kahr WHA , Haq MA, Veljkovic DK, Rivard GE, Hayward CPM. Intracellular activation of the fibrinolytic cascade in the Quebec platelet disorder. Thromb Haemost 2003;90:293-298.
Kahr WHA , Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CPM. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001;98:257-265.
Landolt-Marticorena C, Kahr WHA , Zawarynski P, Correa J, Manolson MF. Substrate-and inhibitor-induced conformational changes in the yeast V-ATPase provide evidence for communication between the catalytic and proton-translocating sectors. J Biol Chem 1999;274:26057-26064. |
|
|
|
 |